Skip to main content
Polaris AI Pharma Corp. logo

Polaris AI Pharma Corp. — Investor Relations & Filings

Ticker · 041910 ISIN · KR7041910001 KO Manufacturing
Filings indexed 164 across all filing types
Latest filing 2022-07-06 Report Publication Anno…
Country KR South Korea
Listing KO 041910

About Polaris AI Pharma Corp.

https://polarisaipharma.com/

Polaris AI Pharma Corp., formerly known as ESTECHPHARMA CO., LTD, is a company engaged in the development, manufacture, and supply of active pharmaceutical ingredients (APIs) and fine chemicals. The company specializes in producing raw materials for generic drugs across various therapeutic categories. Its product portfolio includes APIs for treatments such as anti-thrombosis, anti-ulcer, asthma, and alcohol dependence.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (Non-Deal Roadshow). It provides details such as the date, location, purpose, and the method of distribution for IR materials. Since it is an announcement of an event and the availability of materials rather than the presentation itself, it falls under the category of a regulatory filing announcement.
2022-07-06 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) meeting (기업설명회). It provides the date, time, location, and purpose of the meeting, and mentions that IR materials will be distributed at the event or via the Korea Exchange (KIND) system. Since this is an announcement of an event and the availability of materials rather than the presentation itself, it falls under the Report Publication Announcement (RPA) category.
2022-06-24 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'EstechPharma' (주)에스텍파마 for the period from January 1, 2022, to March 31, 2022. It contains detailed financial data, business operations, and management information, which fits the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-13 Korean
소속부변경
Regulatory Filings Classification · 100% confidence The document is a short, structured announcement regarding a change in the company's market classification (from 'Mid-sized Enterprise' to 'Blue-chip Enterprise') on the stock exchange. It does not constitute a full financial report, proxy, or other major filing, but rather a specific regulatory notification regarding company status. As it does not fit into specific categories like M&A or dividends, it falls under the general regulatory announcement category.
2022-04-29 Korean
[기재정정]사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report) for the company '에스텍파마' (EstechPharma) for the fiscal year 2021 (2021.01.01 - 2021.12.31). It contains detailed financial information, management discussion, and corporate governance details, which corresponds to the definition of an Annual Report (10-K). FY 2021
2022-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (AGM). It details the approval of financial statements, dividend resolutions, director appointments, and the voting outcomes for various agenda items. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2022-03-31 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.